The International Conference on Cancer Therapy and Translational Medicine (CTTM 2026)

The International Conference on Cancer Therapy and Translational Medicine (CTTM 2026) focuses on innovative approaches and advancements in cancer therapy and translational medicine to enhance treatment strategies and patient outcomes.

Key Topics

• Liquid cancer treatments (leukemia and lymphomas)
• Artificial intelligence in cancer treatment
• Targeting rare diseases
• Translational oncology
• Theranostics
• Immunotherapy
• Autophagy and cancer
• Combination therapies
• Drug repurposing
• Oncolytic virus therapy
• Epigenetic therapies
• Liquid biopsy technology
• Microbiome and cancer therapy
• Precision medicine
• Exosome and extracellular vesicle therapy
• Radiation oncology innovations
• Gene therapy in cancer
• Anti-angiogenic therapy
• Tumor microenvironment targeting
• Metabolic targeting in cancer
• CAR-NK and TCR therapies
• Photodynamic therapy (PDT)
• Nanotechnology in cancer therapy
• Novel chemotherapeutics
• Biomarker discovery and validation
• Genome editing and CRISPR technology
• Clinical trials in translational medicine
• Vaccine development
• Regional therapy approaches
• Health disparities in translational medicine
• Microbiome research
• Pharmacogenomics
• Regenerative medicine and stem cell therapy
• Epigenetics and disease therapy
• Organoids and lab-on-chip models
• Nanomedicine
• Overcoming drug resistance
• Translational neuroscience
• Translational research in infectious diseases
• Translational cardiovascular medicine
• Translational psychiatry

Who should Attend

• Biomedical researchers
• Biotechnology professionals
• Healthcare professionals
• Oncologists
• Clinical trial coordinators
• Pharmaceutical industry experts
• Academics and students in translational medicine
• Regenerative medicine specialists
• Radiation oncologists
• Bioinformatics analysts
• Immunotherapy developers
• Stem cell researchers
• Therapeutic strategy innovators
• AI and data science experts in healthcare